CHANGE IN CONTROL AND SEVERANCE AGREEMENTControl and Severance Agreement • February 26th, 2021 • Pacific Biosciences of California, Inc. • Laboratory analytical instruments • California
This Change in Control and Severance Agreement (the “Agreement”) is made and entered into by and between Christian O. Henry (“Executive”) and Pacific Biosciences of California, Inc., a Delaware corporation (the “Company”), effective as of September 14, 2020 (the “Effective Date”).
CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • February 26th, 2021 • Pacific Biosciences of California, Inc. • Laboratory analytical instruments • California
This Change in Control and Severance Agreement (the “Agreement”) is made and entered into by and between Christian O. Henry (“Executive”) and Pacific Biosciences of California, Inc., a Delaware corporation (the “Company”), effective as of February 3, 2021 (the “Effective Date”).
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS ([***]), HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL ANDDevelopment and Commercialization Agreement • February 26th, 2021 • Pacific Biosciences of California, Inc. • Laboratory analytical instruments • California
This DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (the “Agreement”), effective as of January 12, 2021 (the “Effective Date”), is made by and between Pacific Biosciences of California, Inc., a Delaware corporation, having a place of business at 1305 O’Brien Dr., Menlo Park, CA 94025 (“PacBio”) and Invitae Corporation, a Delaware corporation, having a place of business at 1400 16th St., San Francisco, CA 94103 (“Invitae” and, together with PacBio, the “Parties” and each, a “Party”).
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. CEO EMPLOYMENT AGREEMENTEmployment Agreement • February 26th, 2021 • Pacific Biosciences of California, Inc. • Laboratory analytical instruments • California
This CEO Employment Agreement (the “Agreement”), effective as of September 14, 2020, by and between Pacific Biosciences of California, Inc. (the “Company”) and Christian O. Henry (“Executive”).
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • February 26th, 2021 • Pacific Biosciences of California, Inc. • Laboratory analytical instruments • New York
THIS AGREEMENT is effective as of February 1, 2004 (“Effective Date”) between Nanofluidics, Inc. (“LICENSEE”), a corporation of the State of Delaware, that has a principal place of business at 31 Dutch Mill Road, Ithaca, New York 14850, and Cornell Research Foundation, Inc. (“FOUNDATION”), a non-profit corporation of the State of New York, having an office at 20 Thornwood Drive, Suite 105, Ithaca, NY 14850. FOUNDATION and LICENSEE (individually “Party” and collectively, “Parties”) hereby agree as follows:
